Correlations between LncRNA CRNDE and prognosis, immune infiltration of papillary thyroid carcinoma

JU Yuejun; SHEN Ting; CHEN Gang; KONG Yinghong

doi:10.7619/jcmp.20212903

Journal of Clinical Medicine in Practice > 2021 > 25(24): 20-24. > DOI: 10.7619/jcmp.20212903

JU Yuejun, SHEN Ting, CHEN Gang, KONG Yinghong. Correlations between LncRNA CRNDE and prognosis, immune infiltration of papillary thyroid carcinoma[J]. Journal of Clinical Medicine in Practice, 2021, 25(24): 20-24. DOI: 10.7619/jcmp.20212903

Citation:

PDF (2973 KB)

Correlations between LncRNA CRNDE and prognosis, immune infiltration of papillary thyroid carcinoma

1.
Department of Endocrinology, the Second People's Hospital of Changshu in Jiangsu Province, Changshu, Jiangsu, 215500
2.
Ultrasonic Department, the Second People's Hospital of Changshu in Jiangsu Province, Changshu, Jiangsu, 215500

More Information

Received Date: July 20, 2021
Available Online: January 04, 2022
Published Date: December 27, 2021

Graphical Abstract

Abstract

Abstract

Objective To investigate the relationship between LncRNA CRNDE and thyroid papillary carcinoma (PTC).
Methods T-test, Kruskal-Wallis test, Wilcoxon rank-sum test and Chi-square test were used to evaluate the relationship between clinicopathological characteristics and CRNDE expression. The sensitivity and specificity of CRNDE to PTC were described by area under receiver operating characteristic (ROC) curve (AUC). Kaplan-Meier method and Cox regression analysis were used to evaluate factors that affect prognosis. The correlation between CRNDE and immune cells was described by immunoinfiltration analysis.
Results CRNDE expression was increased in PTC, and BRAF V600E mutation was associated with high CRNDE expression in PTC. ROC analysis showed that CRNDE had significant diagnostic ability (AUC=0.839 7). The overall survival (OS) of high CRNDE expression was poor (P=0.012 6), and the expression of CRNDE was independently correlated with the overall survival (OS) of PTC patients (HR=2.131; P=0.001 6). The expression of CRNDE was positively correlated with the infiltration level of B cells, CD8⁺ T cells and macrophages (P < 0.05), and negatively correlated with the infiltration level of CD4⁺ T cells (P < 0.000 1).
Conclusion The expression of CRNDE is significantly related to the survival rate and immune infiltration in PTC, and it may be a promising prognostic biomarker in PTC.
- papillary thyroid carcinoma,
- CRNDE,
- prognosis,
- immune infiltration

FullText(HTML)

References (19)

References

[1]	COCA-PELAZ A, SHAH J P, HERNANDEZ-PRERA J C, et al. Papillary thyroid cancer-aggressive variants and impact on management: a narrative review[J]. Adv Ther, 2020, 37(7): 3112-3128. doi: 10.1007/s12325-020-01391-1
[2]	RAPOSO L, MORAIS S, OLIVEIRA M J, et al. Trends in thyroid cancer incidence and mortality in Portugal[J]. Eur J Cancer Prev, 2017, 26(2): 135-143. doi: 10.1097/CEJ.0000000000000229
[3]	ABDULLAH M I, JUNIT S M, NG K L, et al. Papillary thyroid cancer: genetic alterations and molecular biomarker investigations[J]. Int J Med Sci, 2019, 16(3): 450-460. doi: 10.7150/ijms.29935
[4]	CLARK O H. Thyroid cancer and lymph node metastases[J]. J Surg Oncol, 2011, 103(6): 615-618. doi: 10.1002/jso.21804
[5]	MAZZAFERRI E L, JHIANG S M. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer[J]. Am J Med, 1994, 97(5): 418-428. doi: 10.1016/0002-9343(94)90321-2
[6]	PSTRAG N, ZIEMNICKA K, BLUYSSEN H, et al. Thyroid cancers of follicular origin in a genomic light: in-depth overview of common and unique molecular marker candidates[J]. Mol Cancer, 2018, 17(1): 116. doi: 10.1186/s12943-018-0866-1
[7]	VIERLINGER K, MANSFELD M H, KOPEREK O, et al. Identification of SERPINA1 as single marker for papillary thyroid carcinoma through microarray meta analysis and quantification of its discriminatory power in independent validation[J]. BMC Med Genomics, 2011, 4: 30. doi: 10.1186/1755-8794-4-30
[8]	LOPEZ-CAMPISTROUS A, ADEWUYI E E, BENESCH M G K, et al. PDGFRα regulates follicular cell differentiation driving treatment resistance and disease recurrence in papillary thyroid cancer[J]. EBioMedicine, 2016, 12: 86-97. doi: 10.1016/j.ebiom.2016.09.007
[9]	LI Q, JIN W X, JIN Y X, et al. Clinical effect of MUC1 and its relevance to BRAF V600E mutation in papillary thyroid carcinoma: a case-control study[J]. Cancer Manag Res, 2018, 10: 1351-1358. doi: 10.2147/CMAR.S161501
[10]	JIN K, QIU S, JIN D, et al. Development of prognostic signature based on immune-related genes in muscle-invasive bladder cancer: bioinformatics analysis of TCGA database[J]. Aging, 2021, 13(2): 1859-1871. doi: 10.18632/aging.103787
[11]	LEWINSKI A, ADAMCZEWSKI Z. Papillary thyroid carcinoma: a cancer with an extremely diverse genetic background and prognosis[J]. Pol Arch Intern Med, 2017, 127(6): 388-389. doi: 10.20452/pamw.4058
[12]	FENG J W, QU Z, QIN A C, et al. Significance of multifocality in papillary thyroid carcinoma[J]. Eur J Surg Oncol, 2020, 46(10 pt a): 1820-1828. https://www.sciencedirect.com/science/article/abs/pii/S0748798320305394
[13]	ZEMBSKA A, JAWIARCZYK-PRZYBYŁOWSKA A, WOJTCZAK B, et al. MicroRNA expression in the progression and aggressiveness of papillary thyroid carcinoma[J]. Anticancer Res, 2019, 39(1): 33-40. doi: 10.21873/anticanres.13077
[14]	JARZAB B, WIENCH M, FUJAREWICZ K, et al. Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications[J]. Cancer Res, 2005, 65(4): 1587-1597. doi: 10.1158/0008-5472.CAN-04-3078
[15]	GOODALL G J, WICKRAMASINGHE V O. RNA in cancer[J]. Nat Rev Cancer, 2021, 21(1): 22-36. doi: 10.1038/s41568-020-00306-0
[16]	SUN H, HE L, MA L, et al. LncRNA CRNDE promotes cell proliferation, invasion and migration by competitively binding miR-384 in papillary thyroid cancer[J]. Oncotarget, 2017, 8(66): 110552-110565. doi: 10.18632/oncotarget.22819
[17]	LUO Y H, LIANG L, HE R Q, et al. RNA-sequencing investigation identifies an effective risk score generated by three novel lncRNAs for the survival of papillary thyroid cancer patients[J]. Oncotarget, 2017, 8(43): 74139-74158. doi: 10.18632/oncotarget.18274
[18]	BRUNI D, ANGELL H K, GALON J. The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy[J]. Nat Rev Cancer, 2020, 20(11): 662-680. http://www.nature.com/articles/s41568-020-0285-7
[19]	ZHANG Y, ZHANG Z. The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications[J]. Cell Mol Immunol, 2020, 17(8): 807-821. doi: 10.1038/s41423-020-0488-6

[1]	CAO Xiaohua, DU Fengming, HU Chaoyang, SUN Yan. Construction of a prognostic model for hepatocellular carcinoma based on immune and metabolism related genes and drug prediction[J]. Journal of Clinical Medicine in Practice, 2024, 28(23): 27-35, 41. DOI: 10.7619/jcmp.20241305
[2]	YANG Jingjing, GUO Huaijuan, MAO Jingxian, WANG Jiaxin, WANG Ying, YAN Xuebing, PAN Xiaoping. Construction and validation of a risk model for colorectal cancer prognosis based on N6-methyladenosine modification and immune infiltration[J]. Journal of Clinical Medicine in Practice, 2024, 28(7): 1-8. DOI: 10.7619/jcmp.20240201
[3]	LI Tianyi, REN Yue, SONG Zhenya, JIANG Meinan, LI Mengyang, CHEN Yong, YIN Xudong. Research progress of pan-immune inflammation value in prognosis and effect of tumors[J]. Journal of Clinical Medicine in Practice, 2024, 28(5): 139-143. DOI: 10.7619/jcmp.20233348
[4]	JI Chao, CHEN Yixiao, LIU Kai, SU Xiaochen, TENG Menghao, GUO Yan, JI Wenchen, LI Meng. Screening of diagnostic biomarkers and their relations with immune cell infiltration in osteoporosis[J]. Journal of Clinical Medicine in Practice, 2023, 27(15): 1-6. DOI: 10.7619/jcmp.20231718
[5]	WANG Yuan, LI Jiangtao, JI Qiaoxia, ZHANG Huan, CAI Hongmei, LI Yishuai. Expression of DnaJ heat shock protein family member C9 in lung adenocarcinoma and its value in prognosis[J]. Journal of Clinical Medicine in Practice, 2023, 27(12): 80-87. DOI: 10.7619/jcmp.20231029
[6]	LI Yishuai, WANG Yuan, ZAHNG Lei, ZHU Longyu, QIN Xuebo, DUAN Xiaoliang, WANG Min, LI Jianhang. Expression, prognosis and immune characteristics of zinc finger CCCH domain-containing protein 12D in lung adenocarcinoma[J]. Journal of Clinical Medicine in Practice, 2022, 26(13): 84-92. DOI: 10.7619/jcmp.20220408
[7]	WANG Qiqi, YE Bicheng, WANG Changcheng. Correlation between AHSA1 expression and prognosis of hepatocellular carcinoma based on TCGA database analysis[J]. Journal of Clinical Medicine in Practice, 2022, 26(1): 8-17. DOI: 10.7619/jcmp.20213231
[8]	WEI Xin, LIU Xia, SHI Lin, YUN Fen, JIA Yongfeng. Effect of fucosyltransferase 8 expression on immunecell infiltration and survival prognosis in breast cancer[J]. Journal of Clinical Medicine in Practice, 2021, 25(17): 76-81, 87. DOI: 10.7619/jcmp.20211784
[9]	WEI Min, GUO Honggang, LIU Siwei, XU Fangfang, ZHANG Yin, SHI Jie, XU Zhiwei, CHEN Yuqing. Effect of immune score at initial diagnosis in predicting prognosis in patients with multiple myeloma treated with bortezomib[J]. Journal of Clinical Medicine in Practice, 2021, 25(8): 46-51. DOI: 10.7619/jcmp.20210611
[10]	XIAO Min, ZHOU Xu, LI Sanrong, ZHAO Qiang. Effect of Hashimoto's thyroiditis on degree of necklymph node dissection and prognosis in patients with papillary thyroid carcinoma[J]. Journal of Clinical Medicine in Practice, 2021, 25(6): 29-33. DOI: 10.7619/jcmp.20201635

Cited By

Cited by

Periodical cited type(9)

1.	周柯，徐建欣，邢国征. 尿常规检验中常用四项指标用于老年高血压诊断的效果分析. 婚育与健康. 2024(06): 49-51 .
2.	吴卫林，杨波，钱江远，邹志勇，万美珍，陈丽萍. 依那普利叶酸片联合硝苯地平控释片对高血压患者血压及同型半胱氨酸水平的影响. 中国医学创新. 2023(09): 61-64 .
3.	黄辉民，李以平，夏艳春. 右美托咪定复合阿芬太尼在老年高血压患者内镜逆行性胰胆管造影术中的临床效果及对氧化应激的影响. 中国当代医药. 2023(18): 122-125+130 .
4.	朱明明，李宗虎，郑宪玲，王颖霞，张树杰. 2型糖尿病患者血糖波动与血清网膜素-1及氧化应激因子的关系. 实用临床医药杂志. 2023(20): 113-117 . 本站查看
5.	刘慧，梁婧，谷学兰，陶洪，武琳琳，龙海灯. 2型糖尿病合并高血压患者血清同型半胱氨酸水平与肾功能和颈动脉粥样硬化的相关性分析. 现代生物医学进展. 2022(04): 766-769+790 .
6.	王小荣. 老年隐匿性高血压患者超敏C反应蛋白、尿蛋白、脑钠肽及脉搏波传导速度的关系. 中国医药指南. 2021(10): 64-65 .
7.	宫庭. 马来酸依那普利片联合松龄血脉康胶囊治疗老年高血压的研究. 实用医技杂志. 2021(08): 976-978 .
8.	林佩莉，杨华婷. 比索洛尔对原发性高血压合并收缩性心力衰竭患者心功能及氧化应激的影响. 海峡药学. 2021(09): 81-84 .
9.	王成科，朱欢，董徽徽，胡庆华，胡江平，肖哲，刘晓丽. 运动对高血压患者微血管反应性的干预效应及可能机制研究进展. 中国预防医学杂志. 2021(09): 726-731 .

Other cited types(2)

Get Citation

PDF

XML

Article views (238) PDF downloads (17) Cited by(11)

Turn off MathJax

Article Contents

Abstract

References

Correlations between LncRNA CRNDE and prognosis, immune infiltration of papillary thyroid carcinoma